MoFo BioMeter - Q2 BioMeter Encouraging for Products from Early Development through Phase 2
Posted: September 5, 2013
By: Morrison & Foerster
The average BioMeter value in the second quarter of 2013 was $22.2 million, an increase from the $16.3 million value in the first quarter (excluding BMS/Rickets and AZ/Moderna), and down from $59.4 million in the first quarter (including BMS/Rickets and AZ/Moderna). Find out what drove these increases by downloading this free report.
Share this content with your network.
By clicking this 'Download Now' box, you consent to BioCentury forwarding your information
to the company that wrote this White Paper and you agree that said company can use